In addition, NY-ESO-1 and TSPY-specific IgG have been detected in HCC-patients [33,34], while CT47A1-, PAGE1-, and SLCO6A1-specific antibodies were recently detected in NSCLC patients [35]. This evidence concerns the gene PAGE1 and hepatocellular carcinoma.